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Abstract
Background: Benign central airway tumors are very rare diseases. Their unspecific symptoms are responsible for
late diagnosis. Endoscopic interventions with different techniques and tools are widely used for their treatment.
However, in certain cases interventional endoscopy might be unsuccessful and therefore other methods such as
high-dose-rate brachytherapy could be a therapeutic option.
Case presentation: A 76-year-old white German woman was referred to our clinic for an endoscopic treatment of
a recurrent granulation polyp in her left main bronchus. She had dyspnea, coughing, and mucus retention. Three
times resections via bronchoscopy were performed within less than a year. After each intervention the polyp regrew
inside her left main bronchus causing a repeat of the initial symptoms. She presented to our clinic less than 1 month
since the last intervention. Twice we performed a rigid bronchoscopy in total anesthesia where we resected the
granulation polyp with a snare wire loop and did an argon plasma coagulation of its base. Due to the recurrent growing
of the granuloma, we performed a high-dose-rate brachytherapy in conscious sedation after another interventional
bronchoscopy with a resection of the polyp and argon plasma coagulation of the base. Three months after
brachytherapy our patient came to our clinic for a follow-up with none of the initial symptoms. Only a small
remnant of the polyp without a significant occlusion of her bronchus was visualized by bronchoscopy. Furthermore,
6 months after brachytherapy she was not presenting any of the initial symptoms.
Conclusions: This case report shows that high-dose-rate brachytherapy is a therapeutic option for the treatment of
benign airway stenosis when other interventional treatments are not or are less than successful. However, further
investigations are needed to prove the effectiveness and reliability of the method.
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Background
Benign airway tumors are very rare diseases, especially
in the central airways and their unspecific symptoms are
responsible for delays in diagnosis [1]. Endoscopic inter-
ventions are widely used for their treatment [2]. Differ-
ent techniques and tools such as snare, forceps, or
high-power laser irradiation have been used to remove
the tumors [3]. However, the long period of time until
they are diagnosed and certain cases where interven-
tional endoscopy is not successful show their clinical
relevance and necessitate other therapeutic options such
as high-dose-rate (HDR) brachytherapy.
The following case is about such a patient who had a
recurrent granulation polyp in the upper airways. After a
long period of time with many endoscopic interventional
efforts, finally and unusually, HDR brachytherapy was
performed preventing other numerous interventions,
moreover improving the quality of the patient’s life. This
case could help clinicians in similar situations to take
brachytherapy into account much earlier.
Case presentation
A 76-year-old white German woman was referred to our
clinic for an endoscopic treatment of a recurrent granu-
lation polyp in her left main bronchus (Fig. 1) causing
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dyspnea, coughing, and mucus retention for more than a
year. Furthermore, she had arterial hypertension and
von Willebrand disease (type 2A). She took her antihy-
pertensive medication regularly. When the first interven-
tion took place sarcoidosis was diagnosed by a lymph
node biopsy. Three resections via bronchoscopy were
performed within less than a year. After each interven-
tion the polyp regrew inside her left main bronchus
causing a repeat of the initial symptoms. She presented
to our clinic less than 1 month since the last interven-
tion. Moreover, a corticosteroid therapy over a month
did not prevent polyp growth. No other family member
had the described disease. She used to work as a musi-
cian many years ago (guitar, alto recorder). An exposure
to any toxic substance could not be identified. She lived
with her husband with whom she had three healthy chil-
dren. The medical family history was without patho-
logical findings. On admission her vital signs were
unremarkable: temperature 36 °C, blood pressure 120/
70 mmHg, pulse 84 beats/minute, and breathing rate 14/
minute. In the physical examination she presented a nor-
mal, rhythmic heart sound. Her abdomen was soft, there
was no pressure pain, and peristaltic sounds were heard.
Tapping on the renal bed did not cause any pain. Periph-
eral pulses could be detected. No edema was found. Also,
no paresis, paresthesia, or other neurological abnormality
could be identified. The only pathological finding was an
inspiratory stridor over her lung. Capillary blood gas
analysis showed a respiratory failure with a respiratory al-
kalosis due to compensatory hyperventilation: partial pres-
sure of oxygen (pO2) 65 mmHg, partial pressure of carbon
dioxide (pCO2) 32 mmHg, pH 7.48, base excess 2 mmol/l,
and bicarbonate 26 mmol/l. Apart from a reduced potas-
sium level (3.3 mmol/l), the laboratory findings did not
show any pathological findings.
First we performed a computed tomography to
visualize the polyp (Fig. 1). Twice we performed a rigid
bronchoscopy in total anesthesia where we resected the
granulation polyp (Fig. 2) with a snare wire loop and did
an argon plasma coagulation (APC) of the base (Figs. 3
and 4). APC is used for hemostasis and ablations of le-
sions in endoscopy. It is a form of noncontact electro-
coagulation involving the use of ionized argon gas [4].
After each intervention our patient’s symptoms disap-
peared and she was discharged from our clinic. Due to
the recurrent growing of the granuloma despite inter-
ventional attempts, we planned a HDR brachytherapy as
a therapeutic option with the radiation department.
After informed consent and another interventional bron-
choscopy with a resection of the polyp and APC of the
Fig. 1 a, b Computed tomography with the polyp in the left main bronchus
Fig. 2 a, b Histological image of the granulation polyp: polypoid, discreetly granulocytic granulation tissue along with squamous epithelium
without dysplasia
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base due to another relapse (Fig. 5a), a HDR brachytherapy
was performed in conscious sedation. After visualization of
the tumor with flexible bronchoscopy a flexible
brachytherapy catheter containing seeds was inserted
with the bronchoscope and placed at the target pos-
ition. The bronchoscope was then removed and the
catheter was fixed. The position of the catheter was
confirmed by fluoroscopy. The applied dosage was
four times 5 Gy. The procedure was performed four
times overall and it was well tolerated.
Three months after brachytherapy our patient
came to our clinic for a follow-up. None of the
above mentioned symptoms recurred in the mean-
time. In the performed bronchoscopy only a small
remnant of the polyp without a significant occlusion
of the bronchus was visualized (Fig. 5b). Even
6 months after brachytherapy our patient did not
have any of the initial symptoms.
Discussion
The presented case is about an older woman who
had a single recurrent granulation polyp which was
found in her left main bronchus that repeatedly
caused symptoms such as dyspnea, coughing, and
mucus retention. After many interventional efforts
that could not prevent rapid tumor growth, a HDR
brachytherapy was performed. Hence, numerous in-
terventions could be avoided.
Polyps in the lower respiratory tract are rarely
found and are mostly triggered by former intubations
or previous intervention [5, 6]. In our case no reason
was found. There are different techniques and tools
such as snare, forceps, or high-power laser irradiation
to remove such tumors [3]. We also used these
methods to prevent tumor growth. Due to the recur-
rent polyp and our patient’s repeatedly occurring
symptoms despite the interventional efforts, we decided
Fig. 3 a Endobronchial finding at the time of the first bronchoscopy in our clinic with the granulation polyp that occludes the left main bronchus by
around 50% before ablation and argon plasma coagulation and b after treatment
Fig. 4 a Endobronchial finding 6 weeks after initial intervention in our clinic with the granulation polyp that occludes the left main bronchus by
around 80% before ablation and argon plasma coagulation and b after treatment
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to perform HDR brachytherapy. According to the best of
our knowledge, there is no published case where
brachytherapy has been performed to treat a granula-
tion polyp in the lung.
Brachytherapy has been used very often in cases of
malignant tumors of the lung [7] but there are only
rarely reports in which brachytherapy was performed
in benign airway stenosis. Patients with benign granu-
lation tissue in the airways can be refractory to stand-
ard interventional treatments [8]. Here brachytherapy
should be discussed as a therapeutical method. Cases
of successful brachytherapy in patients with benign
complex tracheobronchial stenosis due to tuberculosis
or intubation have been described [9]. Furthermore,
there is evidence that it might be an effective treat-
ment after lung transplantation when benign granula-
tion tissue leads to severe airway obstruction [10, 11].
Allen et al. showed in a collective with patients with
recurrent tracheal granulation that 66% remained free
of granulation 3 years after endobronchial brachyther-
apy [12]. In our case, our patient did not have any
of the initial symptoms 3 months after the brachy-
therapy. By contrast, after endoscopic intervention
she presented the initial symptoms of dyspnea,
coughing, and mucus retention less than 1 month
after the procedure. Therefore, the number of neces-
sary endoscopic interventions to relieve her symp-
toms decreased after brachytherapy.
Despite the benefits of brachytherapy, the method
has its limitations. Endobronchial brachytherapy can
result in severe bleeding, tissue necrosis, fistula,
pneumothorax, bronchial stenosis, or toxicity-related
death [13]. Furthermore, not every patient will bene-
fit from brachytherapy [12]. Our case shows a min-
imal remnant of the polyp which does not show a
significant occlusion or cause any symptoms. This
could mean that relapses cannot be prevented by
brachytherapy. However, most likely a symptom-free
period can be extended.
Conclusions
This case report shows that HDR brachytherapy is a
therapeutic option for the treatment of benign airway
stenosis when other interventional treatments are not or
are less than successful. However, the method has to be
proved in a higher number of patients and long-term
results have to be evaluated to prove its effectiveness
and reliability.
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Fig. 5 a Endobronchial finding before brachytherapy with the granulation polyp that occludes the left main bronchus by around 50% and b 3 months
after brachytherapy with a minimal remnant of the granulation polyp
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